ABC00645KV

erythromycin Anhydro Erythromycin A

Erythromycin Anhydro Erythromycin A is a dehydration derivative of Erythromycin A, characterized by the loss of a water molecule from the parent macrolide lactone ring, resulting in a conjugated cyclic ketone structure. This impurity retains the 14-membered macrolactam core and glycosidic linkage to cladinose and desosamine moieties but exhibits altered hydrogen bonding capacity due to the anhydro modification. The compound arises via thermal or acidic degradation pathways during erythromycin synthesis or purification. It serves as a critical HPLC reference standard for quantifying process-related impurities in erythromycin APIs.

On Request
Molecular Formula C37H65NO12
Molecular Weight 715.9000
CAS Number 23893-13-2 โœ“ Verified
PubChem CID 83949 โ†—
Purity N/A
Product Type API Impurity
Parent Drug Erythromycin
Lead Time On Request
IUPAC Name (1S,2R,3R,4S,5R,8R,9S,10S,11R,12R,14R)-11-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-5-ethyl-3-hydroxy-9-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-2,4,8,10,12,14-hexamethyl-6,15,16-trioxatricyclo[10.2.1.11,4]hexadecan-7-one
Official Reference Standards
Std Catalog # Quantity Price
USP 1A10290 โ†— 25 mg USD 1050.00

๐Ÿ“ Synonyms

Anhydroerythromycin A 23893-13-2 Erythromycin, 9-deoxo-6,12-dideoxy-6,9:9,12-diepoxy- 2BR5PL6H39 BRL-46355ER DTXSID701016176 EM-202 RefChem:112771 DTXCID801474313 Anhydro Erythromycin A

๐Ÿ”ฌ Chemical Identifiers

CC[C@@H]1[C@@]2([C@@H]([C@H]([C@@]3(O2)[C@@H](C[C@@](O3)([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]4C[C@@]([C@H]([C@@H](O4)C)O)(C)OC)C)O[C@H]5[C@@H]([C@H](C[C@H](O5)C)N(C)C)O)C)C)C)O)C
InChI=1S/C37H65NO12/c1-14-25-36(10)29(40)22(6)37(50-36)18(2)16-35(9,49-37)31(48-33-27(39)24(38(11)12)15-19(3)44-33)20(4)28(21(5)32(42)46-25)47-26-17-34(8,43-13)30(41)23(7)45-26/h18-31,33,39-41H,14-17H2,1-13H3/t18-,19-,20+,21-,22-,23+,24+,25-,26+,27-,28+,29-,30+,31-,33+,34-,35-,36-,37+/m1/s1
YKAVHPRGGAUFDN-JTQLBUQXSA-N

Related Products